当前位置: X-MOL 学术BJU Int. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour
BJU International ( IF 3.7 ) Pub Date : 2024-12-11 , DOI: 10.1111/bju.16618
Luca Antonelli, Axel Heidenreich, Aditya Bagrodia, Armon Amini, Fady Baky, Nicolas Branger, Walter Cazzaniga, Timothy N. Clinton, Siamak Daneshmand, Hooman Djaladat, Scott Eggener, Alireza Ghoreifi, Robert J. Hamilton, Matthew Ho, Wade J. Sexton, Sebastiano Nazzani, David Nicol, Nicola Nicolai, Kathleen Olson, Pia Paffenholz, James Porter, Zhiyu Qian, Nicholas R. Rocco, Anirudh Yerrapragada, Sean P. Stroup, Isamu Tachibana, Angelika Terbuch, Nirmish Singla, Clint Cary, Christian D. Fankhauser

To reassess the role of primary retroperitoneal lymph node dissection (RPLND) in patients with marker-negative non-seminomatous germ cell tumour (NSGCT) clinical stage (CS) 2a, to explore results in patients with CS 2b and to evaluate surgical methods, recurrence, and adjuvant chemotherapy indications.

中文翻译:


临床 2a/b 期非精原细胞瘤生殖细胞瘤的原发性腹膜后淋巴结清扫术



重新评估原发性腹膜后淋巴结清扫术 (RPLND) 在标志物阴性非精原细胞瘤性生殖细胞瘤 (NSGCT) 临床分期 (CS) 2a 患者中的作用,探讨 CS 2b 患者的结果,并评估手术方法、复发和辅助化疗适应症。
更新日期:2024-12-12
down
wechat
bug